TAUFIK KASSIS: Open Payments
NPI 1174545628 · FRENCHBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$721 in 37 payments from 13 companies in 2025. Trend: 2023 $1,116 · 2024 $973 · 2025 $721
Food & beverage: $721
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $192 |
| Gilead Sciences, Inc. | 4 | $86 |
| Dexcom, Inc. | 2 | $65 |
| Lilly USA, LLC | 4 | $64 |
| Phathom Pharmaceuticals, Inc. | 3 | $63 |
| Novartis Pharmaceuticals Corporation | 3 | $57 |
| Braeburn Inc. | 3 | $55 |
| Abbott Laboratories | 2 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $28 |
| Ferring Pharmaceuticals Inc. | 1 | $21 |
Products named: MAVYRET, Dexcom G6 Transmitter, MOUNJARO, VOQUEZNA, BRIXADI, UBRELVY, FREESTYLE LIBRE 3, LEQVIO.
Industry payments across KY — which companies pay providers there.
